Y-mAbs Hosting Virtual Research and Development Day 09 December 2021
NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Hereby an invitation to partake the BRIDGE – Translational Excellence Programme as an industry mentor,... Read more
Press Release NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more
Press Release Copenhagen October 15th 2021 A new collaboration between Symbion Community, REBBLS and... Read more
Press Release NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (“Y-mAbs”... Read more
We have a winner ! As part of the European Commission’s Data 4 Healthy Recovery Hackathon EuropaBio... Read more
PILA PHARMA was listed on Nasdaq First North on July 15. After just over two months, it is time for CEO... Read more
From Ministry of Industry, Business and Financial Affairs (Erhvervsministeriet) we received the following: The... Read more
Press Release Bioneer A/S announces a strategic collaboration with the National Biologics Facility (NBF)... Read more